Post by Michael Okun on X. New drug for. L B D

Michael Okun ⁦‪@MichaelOkun‬⁩ A new drug has shown promise for Dementia with Lewy Bodies in the just released data from the SHIMMER (CT1812) trial. The data just released revealed that participants taking CT1812 performed better across measures of behavior, function, cognition, and movement. The treatment was… pic.twitter.com/Tr1ajZQGTO 12/19/24, 9:34 AM Joseph Thornton

Post by Nutrition Science on X. Glp1 drugs scope

Nutrition Science ⁦‪@NutrioSci‬⁩ Are GLP-1 drugs really for everybody? ⁦‪@NatureMedicine‬⁩ #MedEd #MedX #obesity #GLP1 “How genetic, clinical and sociodemographic differences impact their effects on weight loss.” Open Access nature.com/articles/s4159… pic.twitter.com/LGnfR3SdbC 12/3/24, 3:46 AM Joseph Thornton

Post by Beverly G. Tchang, MD on X. Obesity grand rounds

Beverly G. Tchang, MD ⁦‪@BevTchangMD‬⁩ Looking for an intro on the State of #Obesity #Medicine? Check out my ⁦‪@WeillCornell‬⁩ Medicine Grand Rounds drive.google.com/file/d/10tKQwx… I discuss: 👉What makes obesity a disease? 👉How do genetics and environment cause obesity? 👉How do we use on- and off-label anti obesity… pic.twitter.com/edj00tCSAW 10/13/23, 6:32 AM Joseph Thornton